SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-027697
Filing Date
2021-11-09
Accepted
2021-11-09 17:20:23
Documents
91
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 2058848
2 ex10-3.htm EX-10.3 185067
3 ex10-4.htm EX-10.4 195763
4 ex31-1.htm EX-31.1 18311
5 ex31-2.htm EX-31.2 16904
6 ex32-1.htm EX-32.1 8021
  Complete submission text file 0001493152-21-027697.txt   9992704

Data Files

Seq Description Document Type Size
7 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hrow-20210930.xsd EX-101.SCH 66190
8 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hrow-20210930_cal.xml EX-101.CAL 95007
9 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hrow-20210930_def.xml EX-101.DEF 320356
10 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hrow-20210930_lab.xml EX-101.LAB 545237
11 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hrow-20210930_pre.xml EX-101.PRE 430508
12 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1766012
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 211393326
SIC: 2834 Pharmaceutical Preparations